AlphAIAlphAI — Financial news for AI agents
fool.comOCT 293 min read$THC

Tenet (THC) Q3 2026 Earnings Call Transcript

Tenet Healthcare (THC) reported Q3 2026 revenue of $5.631B (+6.5% YoY) and adjusted EPS of $6.64 (+79.5% YoY). Adjusted EBITDA was $1.355B, with growth in ambulatory and hospital segments. The company raised FY2026 EBITDA guidance to $5.05B-$5.20B. Risks include an 18% decline in exchange admissions and Medicaid work requirements. Tenet issued $2B in senior unsecured notes and repurchased $1.615B in shares YTD.

Original reporting
fool.com
Published Oct 29, 2026, 7:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tenet (THC) Q3 2026 Earnings Call Transcript — source image
Source · fool.com
Decision brief

The 30-second read

$THCBullishHigh
01

Why it matters

The earnings beat and raised guidance are likely to drive short-term buying interest, though sector-specific challenges remain.

02

Market read

First-report earnings with multi‑billion dollar figures; material for traders and investors.

03

What to watch

Potential Medicaid work requirement impacts and 18% drop in exchange admissions could affect future earnings.

Relevance 9/10Novelty 9/10Timing: after-hours today

Background

Tenet Healthcare held its Q3 2026 earnings call, providing detailed financial results and forward guidance.

Company-level read

Ticker impact

$THCBullishHigh confidence
Context

Q3 2026 earnings released with $5.631B revenue, $6.64 adjusted EPS and raised FY 2026 adjusted EBITDA guidance.

Expected impact

likely modest upside as market prices in strong earnings and higher guidance

Evidence & confidence

Revenue and EPS beat expectations; FY 2026 EBITDA outlook increased, supporting a bullish reaction.

Market effects

Sector

Healthcare sector may benefit from Tenet's strong earnings and growth outlook.

Regional

U.S. equity markets could see a modest lift from the results.

Global

Moderate, as Tenet is a large U.S. health services provider.

Counterpoint

What could challenge this read

Valuation may be stretched; headwinds from exchange admission declines could temper upside.

Key entities

  • company
    Tenet Healthcare Corporation

    U.S.-listed health services operator reporting Q3 2026 results.

Read at source← All news

StoryTenet Healthcare posts strong Q3 2026 results and raises FY2026 outlook

Also covered by

4 outlets

Related articles

OCT 31
$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.

finance.yahoo.com6 min
OCT 30
$THCMed

High-acuity strategy helped Tenet weather surgery, uninsured headwinds in Q3

Tenet Healthcare raised its 2026 earnings guidance after its focus on high-acuity surgeries helped offset Q3 declines in procedure volumes. CEO Saum Sutaria cited the strategy's role in mitigating financial headwinds, including rising uninsured rates. Tenet expects full-year net income of $2.97B-$3.08B on revenues of $22.1B-$22.5B. Analysts noted Tenet's results were solid despite a challenging hospital sector.

finance.yahoo.com6 min
OCT 30
$THCMedAI 8/10

Guggenheim lowers Tenet Healthcare stock price target on 2027 outlook

Guggenheim reduced its price target for Tenet Healthcare (NYSE:THC) to $306 from $307, maintaining a Buy rating. The firm cited a modestly revised 2027 EBITDA outlook. Tenet's Q3 2026 earnings beat estimates, with adjusted EPS of $6.64 vs. $4.67 and revenue of $5.63B vs. $5.49B. The stock trades at $270.57, with a P/E ratio of 10.36 and a free cash flow yield of 15%.

investing.com2 min
OCT 29
$THCMedAI 8/10

Tenet Healthcare Corp (THC) Q3 2026 Earnings Call Highlights: Strong EPS Growth

Tenet Healthcare Corp (THC) reported Q3 2026 adjusted diluted EPS of $6.64, up 80%, driven by strong core business growth. USPI adjusted EBITDA rose 9% to $537 million, while hospital segment admissions grew 3.2%. Full-year 2026 adjusted EBITDA guidance was raised by $195 million. Challenges include exchange admissions decline and Conifer transition impacts. Management remains optimistic about 2027 earnings growth.

finance.yahoo.com6 min
OCT 29
$THCMedAI 9/10

Tenet Healthcare Boosts FY26 Earnings Outlook - Update

Tenet Healthcare (THC) raised its FY26 earnings and adjusted earnings guidance, while narrowing its revenue outlook. The company now expects earnings of $35.82-$37.08 per share, adjusted earnings of $22.05-$23.01 per share, and revenue of $22.05-$22.45 billion. Shares were unchanged at $268.50 in pre-market trading.

rttnews.com2 min